European MedTech shares rise after tariff U.S.-China trade deal

Published 12/05/2025, 11:06
© Reuters.

Investing.com -- Shares of Philips (NYSE:PHG), Siemens (ETR:SIEGn) Healthineers (ETR:SHL), and Carl Zeiss Meditec (ETR:AFX) witnessed solid gains in today’s trading session in the wake of a pivotal weekend meeting in Geneva between the U.S. and Chinese governments, where both parties agreed to scale back their reciprocal tariffs on imports significantly for a 90-day period.

Among bigger movers, Philips shares are up 5%, Siemens Healthineers rose 4.2%, and Carl Zeiss Meditec increasing by 4.8% following the news.

The U.S. announced a reduction of tariffs to 30% from a previous 145%, while China will lower its tariffs to 10% from 125%. This easing of trade tensions is seen as a substantial positive for the MedTech industry, which had been facing notable headwinds due to the tariffs.

The reduced tariffs are likely to alleviate cost pressures and improve the profitability outlook for these companies. Analysts from UBS commented on the development, stating, "We think this is a significant positive for MedTech and specifically for recently upgraded GE Healthcare (Neutral) within our coverage as well as Philips (Buy), Biomerieux (EPA:BIOX) (Buy) and Siemens Healthineers (Neutral) whilst there may be indirect positive effects for Carl Zeiss Meditec (Neutral) too."

They further elaborated on the financial impact, "US/China reciprocal tariffs were a meaningful (>5% of EBIT) headwind for a number of companies in our coverage given China is often the major supplier of key electronic components or rare earth minerals for products sold in the US whilst some legacy US manufacturing footprint is used for the export of key products (in particular diagnostic reagents) used in China."

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.